Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover, double-blind trial
Bardia Nourbakhsh, Nisha Revirajan, Bridget Morris, Christian Cordano, Jennifer M. Creasman, Michael Manguinao, Kristen M. Krysko, Alice Rutatangwa, Caroline Auvray, Salman Aljarallah, Chengshi Jin, Ellen M. Mowry, Charles E. McCulloch, Emmanuelle Waubant
Topics & Concepts
ModafinilAmantadineMethylphenidateCrossover studyPlaceboMedicineDouble blindMultiple sclerosisAnesthesiaPsychologyPharmacologyPsychiatryAttention deficit hyperactivity disorderAlternative medicinePathologyMultiple Sclerosis Research StudiesLong-Term Effects of COVID-19Peripheral Neuropathies and Disorders